- Home
- FTK vs BIOA Comparison
FTK vs BIOA Comparison
Compare FTK & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTK | BIOA |
|---|---|---|
| Founded | 1985 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 527.8M | 443.9M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | FTK | BIOA |
|---|---|---|
| Price | $17.11 | $19.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $20.00 | ★ $33.33 |
| AVG Volume (30 Days) | 366.0K | ★ 1.0M |
| Earning Date | 03-09-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 242.12 | N/A |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $220,501,000.00 | $5,917,000.00 |
| Revenue This Year | $20.33 | N/A |
| Revenue Next Year | $12.59 | N/A |
| P/E Ratio | $18.71 | ★ N/A |
| Revenue Growth | ★ 23.56 | N/A |
| 52 Week Low | $6.05 | $2.88 |
| 52 Week High | $20.09 | $24.00 |
Technical Indicators
Market Signals| Indicator | FTK | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 58.91 |
| Support Level | $16.75 | $18.20 |
| Resistance Level | $18.68 | $19.88 |
| Average True Range (ATR) | 1.17 | 1.91 |
| MACD | -0.01 | -0.28 |
| Stochastic Oscillator | 45.85 | 46.12 |
Price Performance
Historical ComparisonAbout FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.